Skip navigation.

Welcome to SAfAIDS

SAfAIDS news

Zimbabwe: Fears Mount Over Drug-Resistant HIV

HARARE, 10 February 2016 (allAfrica) - At least 60 percent of people living with HIV in Sub-Saharan Africa, including Zimbabwe, are becoming resistant to the key anti-retroviral drug, Tenofovir, raising fears among scientists that a strain of virus resistant to drugs might have developed.

Moderate alcohol consumption may be more harmful to people with HIV

USA, 10 February 2016 (aidsmap)-Safe drinking limits for people living with HIV may be lower than the recommendations for the rest of the population, a large US cohort study suggests, especially in people not taking antiretroviral therapy. The findings are published by the journal Drug and Alcohol Dependence.

Cutting prison sentences could reduce spread of HIV, study suggests

OXFORD, 9 February 2016 (EurekAlert) - Reducing the number of men who go to prison could help curb the spread of HIV and other sexually transmitted infections in a community, according to research published in Social Science & Medicine.

Nigeria Tops List of Countries Providing Contraceptives

LAGOS, 2 February 2016 (allAfrica) - Nigeria provided 22 per cent of the contraceptives provided by the top 10 contraceptives providing countries in 2013 and 2014. Out of a total of 8,153,431 contraceptives provided for the two years, Nigeria provided 3,873,115. In 2013, Africa's most populous country provided 1,835,966 contraceptives, a figure that increased to 2,037,149 in 2014 according to data released by the Family Planning 2020, FP2020, at the just concluded 4th International Conference on Family Planning, ICFP 2016, held in Nusa Dua, Indonesia.

HIV becoming resistant to key drug, study finds

LONDON, 28 January (BBC News)-Strains of HIV are becoming resistant to an antiretroviral drug commonly used to prevent and fight the virus, research has suggested.

PEPFAR's Dr Deborah Birx urges sharper focus to halt HIV globally

Bethseda, 28 January 2016 (Fogarty International center)-To protect and extend the significant progress made against the HIV/AIDS epidemic globally, policymakers and funders must target specific high-risk populations,

Syndicate content